Overview
TNDM market data
Price History
TNDM price chart · 1M
- O
- 21.09
- H
- 21.93
- L
- 21.09
- C
- 21.47
- Vol
- 66,786.00
- Source
- US equities market feed
- Observed
- Aug 27, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $21.09
- Previous Close
- $21.35
- Day High
- $21.93
- Day Low
- $21.09
- 52 Week High
- $24.76
- 52 Week Low
- $12.28
- 7 Day Return
- -4.96%
- 30 Day Return
- +20.89%
- 90 Day Return
- +24.68%
- 1 Year Return
- +18.23%
- Daily Notional Volume
- $1.4M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$3.04 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.61 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -6.1% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $11.46 – $29.65 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $1.6B · P/B 9.60 · P/S 1.55.
Company News
FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose TrackingBenzinga · Aug 26, 2026, 1:36 PM
William Blair Initiates Coverage On Tandem Diabetes Care with Outperform RatingBenzinga · Aug 21, 2026, 8:14 PM
Innovative Insulin Pumps Drive Optimism for Tandem, Beta BionicsBenzinga · Aug 21, 2026, 5:31 PM
Airsculpt Technologies, Barrick Mining And Other Big Stocks Moving Lower In Monday’s Pre-Market SessionBenzinga · Aug 10, 2026, 12:02 PM
Citigroup Maintains Neutral on Tandem Diabetes Care, Raises Price Target to $21Benzinga · Aug 7, 2026, 8:55 PM
RBC Capital Maintains Outperform on Tandem Diabetes Care, Lowers Price Target to $26Benzinga · Aug 7, 2026, 8:19 PM
Tandem Diabetes Care shares are trading higher after the company reported better-than-expected Q2 EPS results and reaffirmed its FY2026 sales guidance.Benzinga · Aug 7, 2026, 3:59 PM
Tandem Diabetes Care Q2 EPS $(0.31) Beats $(0.32) Estimate, Sales $254.560M Miss $254.978M EstimateBenzinga · Aug 6, 2026, 8:25 PM
Tandem Diabetes Care Affirms FY2026 Sales Guidance of $1.065B-$1.085B vs $1.074B EstBenzinga · Aug 6, 2026, 8:23 PM
Shares of medical device companies are trading higher amid sympathy with Abbott Laboratories after that company reported better-than-expected Q2 financial results and raised its FY adjusted EPS guidance with its midpoint above estimates.Benzinga · Jul 16, 2026, 4:35 PM